A Case of Acute Myocardial Infarction Induced by Selective Cyclooxygenase-2 Inhibitor

To the Editor: A 46‐year‐old male, having a history of coronary artery disease, and coronary artery bypass graft surgery (CABG), was admitted to our clinic with sustained chest pain. He had a left internal mammary artery to the left anterior descending coronary artery, saphenous vein graft (SVG) to diagonal branch, and SVG to obtuse marginal artery. Up to 7 years after CABG, patient had no complaints of chest pain. Two days before admission, medications were administered for back pain: aceclofenac (selective cyclooxygenase‐2 [COX‐2] inhibitor), orphenadrine (muscle relaxant), and alibendol (digestant). Intermittent chest pain began after taking the drugs, which aggravated and were sustained for 4 h before admission.

• Publication year

  2017

• Venue

  Chinese Medical Journal

• Publication date

  2017-05-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/0366-6999.204919PMID 28469113PMCID 5421188
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxidative Stress-Dependent Coronary Endothelial Dysfunction in Obese Mice

  2015cited by this paper
• Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

  2006cited by this paper
• Coxibs and cardiovascular disease.

  2004cited by this paper

• Lists of potentially inappropriate medications for older people in primary care: a systematic review of health outcomes

  2024cites this paper
• Urapidil, compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis

  2018cites this paper
• Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs

  2017cites this paper